BIO vs PRLB · rev $2.58B vs P/E 75, $1.89B cap
BIO (BIO) versus Proto Labs Inc (PRLB) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
PRLB does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. PRLB currently screens at market cap $1.89B and trailing P/E 75.1.
Not investment advice. Open the BIO and PRLB stock pages for the full models.
Not investment advice.